Evidence map›Paper›PMID 29761125›Full record

ArticleAnnals of clinical and translational neurology2018

Inflammation is a key risk factor for persistent seizures in neurocysticercosis.

Jesica A Herrick, Biswajit Maharathi, Jin Suh Kim, Gerardo G Abundis, Anjali Garg, Isidro Gonzales, Herbert Saavedra, Javier A Bustos, Hector H Garcia, Jeffrey A Loeb and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Human Neurocysticercosis: An Overview.Pathogens (Basel, Switzerland) · 2022
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Frequency and Determinant Factors for Calcification in Neurocysticercosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Article
  18. Unique Characteristics of Epilepsy Development in Neurocysticercosis.The American journal of tropical medicine and hygiene · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jesica A HerrickDivision of Infectious Diseases, Immunology, and International Medicine University of Illinois at Chicago Chicago Illinois.ORCID 0000-0001-5509-6458
Biswajit MaharathiDepartment of Neurology and Rehabilitation Medicine University of Illinois at Chicago Chicago Illinois.
Jin Suh KimDepartment of Radiology University of Illinois at Chicago Chicago Illinois.
Gerardo G AbundisDivision of Infectious Diseases, Immunology, and International Medicine University of Illinois at Chicago Chicago Illinois.
Anjali GargDepartment of Neurology and Rehabilitation Medicine University of Illinois at Chicago Chicago Illinois.
Isidro GonzalesCenter for Global Health - Tumbes Department of Microbiology Universidad Peruana Cayetano Heredia, and Cysticercosis Unit Instituto Nacional de Ciencias Neurológicas Lima Perú.
Herbert SaavedraCenter for Global Health - Tumbes Department of Microbiology Universidad Peruana Cayetano Heredia, and Cysticercosis Unit Instituto Nacional de Ciencias Neurológicas Lima Perú.
Javier A BustosCenter for Global Health - Tumbes Department of Microbiology Universidad Peruana Cayetano Heredia, and Cysticercosis Unit Instituto Nacional de Ciencias Neurológicas Lima Perú.
Hector H GarciaCenter for Global Health - Tumbes Department of Microbiology Universidad Peruana Cayetano Heredia, and Cysticercosis Unit Instituto Nacional de Ciencias Neurológicas Lima Perú.
Jeffrey A LoebDepartment of Neurology and Rehabilitation Medicine University of Illinois at Chicago Chicago Illinois.
Cysticercosis Working Group in Peru
University of Illinois Chicago · USUniversidad Peruana Cayetano Heredia · PE

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Center for Clinical and Translational ScienceUL1TR000050 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AZAR, DIMITRI T, MERMELSTEIN, ROBIN J. · 2012 to 2014
$9.8M
Training in Parasitic Diseases and Central Nervous System Infections in Peru.D43TW001140 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO, GILMAN, ROBERT H · 1999 to 2025
$5.7M
FIC NIH HHS D43 TW001140NCATS NIH HHS UL1 TR000050NCATS NIH HHS UL1 TR002003
6 · The paper itself

Abstract

objectiveWe conducted a retrospective, case-control study of neurocysticercosis patients to ascertain early markers that identify subjects likely to develop treatment-resistant seizures.

methodsClinical histories and imaging studies from 38 neurocysticercosis patients who had been followed for 18 months after treatment were evaluated. Both pairwise and multifactorial analyses were conducted to identify factors associated with continued seizures.

resultsEleven of 38 patients continued to have seizures during the follow-up period. On univariate analysis, the number of neurocysticercosis lesions, number of bands on the baseline neurocysticercosis western blot, edema volumes on follow-up MRI scans, edema volume changes between baseline and follow-up images, and proportion of calcified lesions with perilesional edema were all significantly increased in subjects who had persistent seizures during the 18-month follow-up period. On multivariate analyses using recursive partition and random forest algorithms, variables associated with persistent seizures included: the number of total and calcified lesions, presence of perilesional edema, the rate of change in the lesion and edema volumes from baseline to follow-up, and the number of bands on the neurocysticercosis western blot.

interpretationMeasures of both inflammation and disease burden are key risk factors for persistent seizures despite anticonvulsant treatments in patients with neurocysticercosis. Inflammation is therefore a potentially modifiable risk factor for the frequently seen severe seizure disorders in patients with neurocysticercosis.

Identifiers

PMID29761125
PMCPMC5945963
OpenAlexW2802526287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.